These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 25613287)

  • 1. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
    Kantele A; Lääveri T; Mero S; Vilkman K; Pakkanen SH; Ollgren J; Antikainen J; Kirveskari J
    Clin Infect Dis; 2015 Mar; 60(6):837-46. PubMed ID: 25613287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study.
    Angelin M; Forsell J; Granlund M; Evengård B; Palmgren H; Johansson A
    Travel Med Infect Dis; 2015; 13(3):223-9. PubMed ID: 25982453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.
    Woerther PL; Andremont A; Kantele A
    J Travel Med; 2017 Apr; 24(suppl_1):S29-S34. PubMed ID: 28520999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae-a prospective cohort study.
    Reuland EA; Sonder GJ; Stolte I; Al Naiemi N; Koek A; Linde GB; van de Laar TJ; Vandenbroucke-Grauls CM; van Dam AP
    Clin Microbiol Infect; 2016 Aug; 22(8):731.e1-7. PubMed ID: 27223840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study.
    Kantele A; Mero S; Kirveskari J; Lääveri T
    Travel Med Infect Dis; 2017; 16():23-30. PubMed ID: 28153711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.
    Ostholm-Balkhed A; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
    J Antimicrob Chemother; 2013 Sep; 68(9):2144-53. PubMed ID: 23674762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.
    Mizuno Y; Miura Y; Yamaguchi T; Matsumoto T
    Travel Med Infect Dis; 2016; 14(6):561-567. PubMed ID: 27769900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis.
    Wuerz TC; Kassim SS; Atkins KE
    Travel Med Infect Dis; 2020; 37():101823. PubMed ID: 32755674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.
    Lääveri T; Vlot JA; van Dam AP; Häkkinen HK; Sonder GJB; Visser LG; Kantele A
    BMC Infect Dis; 2018 Jul; 18(1):341. PubMed ID: 30037325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Despite Predominance of Uropathogenic/Extraintestinal Pathotypes Among Travel-acquired Extended-spectrum β-Lactamase-producing Escherichia coli, the Most Commonly Associated Clinical Manifestation Is Travelers' Diarrhea.
    Kantele A; Lääveri T; Mero S; Häkkinen IMK; Kirveskari J; Johnston BD; Johnson JR
    Clin Infect Dis; 2020 Jan; 70(2):210-218. PubMed ID: 31034006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Travelers' health problems and behavior: prospective study with post-travel follow-up.
    Vilkman K; Pakkanen SH; Lääveri T; Siikamäki H; Kantele A
    BMC Infect Dis; 2016 Jul; 16():328. PubMed ID: 27412525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers' Diarrhea.
    Kantele A; Mero S; Kirveskari J; Lääveri T
    Emerg Infect Dis; 2016 Jan; 22(1):117-20. PubMed ID: 26691898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged carriage and potential onward transmission of carbapenemase-producing Enterobacteriaceae in Dutch travelers.
    van Hattem JM; Arcilla MS; Bootsma MC; van Genderen PJ; Goorhuis A; Grobusch MP; Molhoek N; Oude Lashof AM; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
    Future Microbiol; 2016 Jul; 11():857-64. PubMed ID: 27357522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial commentary: Antibiotic self-treatment of travelers' diarrhea: helpful or harmful?
    Connor BA; Keystone JS
    Clin Infect Dis; 2015 Mar; 60(6):847-8. PubMed ID: 25613288
    [No Abstract]   [Full Text] [Related]  

  • 17. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.
    Arcilla MS; van Hattem JM; Haverkate MR; Bootsma MCJ; van Genderen PJJ; Goorhuis A; Grobusch MP; Lashof AMO; Molhoek N; Schultsz C; Stobberingh EE; Verbrugh HA; de Jong MD; Melles DC; Penders J
    Lancet Infect Dis; 2017 Jan; 17(1):78-85. PubMed ID: 27751772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors.
    Kuenzli E; Jaeger VK; Frei R; Neumayr A; DeCrom S; Haller S; Blum J; Widmer AF; Furrer H; Battegay M; Endimiani A; Hatz C
    BMC Infect Dis; 2014 Oct; 14():528. PubMed ID: 25270732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study.
    ÖstholmBalkhed Å; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
    PLoS One; 2018; 13(10):e0205504. PubMed ID: 30356258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016-2017).
    Meurs L; Lempp FS; Lippmann N; Trawinski H; Rodloff AC; Eckardt M; Klingeberg A; Eckmanns T; Walter J; Lübbert C;
    Travel Med Infect Dis; 2020; 33():101521. PubMed ID: 31770602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.